Page 3 - Sohini Das

Dr Lal back on the acquisition trail, tests South India for opportunities

After a three-year strategic pause, diagnostics firm is unlocking its balance-sheet capacity look for growth-boosting acquisitions

India's auto component firms go digital amid world crises, EVs: Report

Digitalisation, automation and smart factories no longer a luxury for sector, it says

Tata Motors bags order to supply 70,000 commercial vehicles to Indonesia

Tata Motors has signed an agreement to supply 70,000 commercial vehicles to Indonesia through its local subsidiary, marking the largest single international CV order, industry insiders said

Stellantis-Tata Motors JV turns 20, signs new MoU for collaboration

Stellantis and Tata Motors Passenger Vehicles marked 20 years of their joint venture by signing a fresh MoU to explore deeper collaboration across manufacturing, engineering and supply chains

Zydus Lifesciences Q3 net profit rises 9% on strong US and India growth

Zydus Lifesciences posted higher Q3 profit and revenue, aided by strong growth in the US and India businesses, improved margins, and steady momentum in generics, specialty and chronic segments

India-US trade deal: Cheaper Harleys likely to test Enfield's pricing power

The tariff removal will lower prices of Harley's large-displacement imported motorcycles, which retail between ₹14.5 lakh and ₹45.8 lakh

Mahindra group to invest ₹15,000 crore over 10 years in Nagpur unit

Group would establish its largest integrated manufacturing facility for automobiles and tractors around the city

Next phase of growth is about improving utilisation: Surendran Chemmenkotil

In a video-interview with Sohini Das, Surendran Chemmenkotil, Managing Director of Metropolis Healthcare, speaks about the company's FY27 network expansion strategy

JLR cyberattack, labour Code weigh on Tata Motors Passenger Vehicles profit

Tata Motors Passenger Vehicles slipped into a loss in Q3FY26 due to costs linked to a JLR cyber attack and regulatory provisions, even as domestic retail demand stayed robust, led by SUVs

Jaguar Land Rover to start production of premium cars at Tamil Nadu unit

Jaguar Land Rover will begin assembling premium cars at its new Tamil Nadu plant on February 9, marking a step towards full-scale luxury car manufacturing in India

Non-animal testing can cut drug costs by up to 90%, says report

Dr Reddy's, Biocon and Sun Pharma are exploring human-based testing methods that could halve drug development timelines and sharply reduce costs, while meeting global regulatory standards

Emcure Q3 results: PAT jumps 48% as India, overseas revenues surge

Pune-based Emcure Pharma posted strong Q3 FY26 results on double-digit domestic and international growth, as it eyes entry into India's top 10 drugmakers

Tariff reset lifts India's medical device pulse amid China+1 shift

For Indian medical device exporters, the tariff reset addresses a long-standing vulnerability: wafer-thin margins

US-India tariff reset lifts engineering exports; auto components lead gains

India's engineering exports to the US are set to regain momentum after reciprocal tariffs were cut to 18%, with auto component makers expected to benefit the most

US tariff cut likely to benefit Indian auto component makers more than OEMs

Brokerages and industry bodies say easing US reciprocal tariffs to 18% will materially boost competitiveness and exports of Indian auto component makers, while gains for vehicle OEMs remain limited

Sun Pharma sees US generics stabilising, pins growth on innovation push

Sun Pharmaceutical Industries expects pressure on its US generics business to ease as compliance improves, while focusing growth efforts on innovation-led therapies

Union Budget 2026-27: Over ₹1 trillion earmarked for the nation's health

Biopharma Shakti initiative to tackle burden of non-communicable diseases, turn India into global, innovation-led hub

Budget 2026: Biopharma to medical tourism, push for healthcare value chain

In Union Budget 2026, FM Nirmala Sitharaman announces ₹10,000 cr Mission Biopharma Shakti, 1,000 clinical trial sites, 10,000 new medical seats, Customs relief on key drugs, and 5 medical tourism hubs

Jeep places India at centre of Asia-Pacific strategy under Jeep 2.0 plan

Jeep outlines a renewed regional roadmap with higher localisation, export expansion and focus on products and ownership experience amid intense competition in India's SUV market

India leads but China narrows gap in South Africa's passenger vehicle track

China-assembled cars have doubled their share of the market